• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS¿ SAMPLE PREP ASSISTANT III; AUTOMATED PIPETTING, DILUTING AND SPECIMEN PROCESSING WORKSTATIONS FOR FLOW CYTO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACS¿ SAMPLE PREP ASSISTANT III; AUTOMATED PIPETTING, DILUTING AND SPECIMEN PROCESSING WORKSTATIONS FOR FLOW CYTO Back to Search Results
Catalog Number 647205
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/02/2023
Event Type  Injury  
Event Description
It was reported that erroneous results were observed during use with the bd facs¿ sample prep assistant iii.The following information was provided by the initial reporter: were patient samples involved? yes.Were erroneous results reported to the clinician? yes.Were patients treated based on erroneous results? yes.(b)(6): (b)(6) 2023 07:57:29 (gmt).Erroneous results.
 
Manufacturer Narrative
D.4.Medical device expiration date: na.H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Manufacturer Narrative
B.1- adverse event type: changed from- "product problem" to "reported issue is both an adverse event and product problem".B.3-event attributed to - changed fromblank to "other".B.4- other details - changed from blank to "patients were assumed to be defaulting on their arv regime, which was not the case".B.7 - describe event or problem- changed from: "it was reported that erroneous results were observed during use with the bd facs¿ sample prep assistant iii.The following information was provided by the initial reporter: were patient samples involved? yes.Were erroneous results reported to the clinician? yes.Were patients treated based on erroneous results? yes.(b)(6) : (b)(6) 2023 07:57:29 (gmt) erroneous results" to "it was reported that erroneous results were observed during use with the bd facs¿ sample prep assistant iii.The following information was provided by the initial reporter: erroneous results was it obvious that the results were erroneous/could not be trusted? yes, our clients had repeated the tests at other laboratories and the results were completely different from ours is a confirmatory test always performed? yes, we do a re run for all cd4 absolute values of less than 150 cells/ul were patient samples involved? yes.Were erroneous results reported to the clinician? yes.Were patients treated based on erroneous results? yes.If yes, was there any negative impact to the patient? yes , patients were assumed to be defaulting on their arv regime, which was not the case".H.1- "type of reportable event" changed from "malfunction" to "serious injury".
 
Event Description
It was reported that erroneous results were observed during use with the bd facs¿ sample prep assistant iii.The following information was provided by the initial reporter: erroneous results was it obvious that the results were erroneous/could not be trusted? yes, our clients had repeated the tests at other laboratories and the results were completely different from ours is a confirmatory test always performed? yes, we do a re run for all cd4 absolute values of less than 150 cells/ul were patient samples involved? yes.Were erroneous results reported to the clinician? yes.Were patients treated based on erroneous results? yes.If yes, was there any negative impact to the patient? yes , patients were assumed to be defaulting on their arv regime, which was not the case.
 
Event Description
It was reported that erroneous results were observed during use with the bd facs¿ sample prep assistant iii.The following information was provided by the initial reporter: erroneous results.Was it obvious that the results were erroneous/could not be trusted? yes, our clients had repeated the tests at other laboratories and the results were completely different from ours is a confirmatory test always performed? yes, we do a re run for all cd4 absolute values of less than 150 cells/ul were patient samples involved? yes.Were erroneous results reported to the clinician? yes.Were patients treated based on erroneous results? yes.If yes, was there any negative impact to the patient? yes , patients were assumed to be defaulting on their arv regime, which was not the case.
 
Manufacturer Narrative
The following field was updated with corrected information: h.6.Imdrf annex f code: f23.Investigation summary: based on the investigation results, the reported issue erroneous results was not confirmed.Investigation results that were performed on the indicated failure mode were the following: dhr for spa pn647205 and sn: (b)(6) was reviewed.The product met all the manufacturing specifications prior to release.Dom: 11/09/2015.Dhr#1532972.Fse contacted customer for access to the instrument for failure analysis.The customer has been unresponsive and therefore no service visit has occurred, nor has any additional information been obtainable.Recommendation was to replace the spa unit as they were unable to find fault on this specific system, the customer refused installation of the new spa due to the customer is not planning on purchasing any more reagents.Potential cause: based on the investigation results, the potential cause was not determined.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACS¿ SAMPLE PREP ASSISTANT III
Type of Device
AUTOMATED PIPETTING, DILUTING AND SPECIMEN PROCESSING WORKSTATIONS FOR FLOW CYTO
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer Contact
jennifer suh
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17646541
MDR Text Key322223902
Report Number2916837-2023-00173
Device Sequence Number1
Product Code PER
UDI-Device Identifier00382906472052
UDI-Public00382906472052
Combination Product (y/n)N
Reporter Country CodeSF
PMA/PMN Number
K131301
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 01/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number647205
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/08/2023
Initial Date FDA Received08/29/2023
Supplement Dates Manufacturer Received08/29/2023
01/13/2024
Supplement Dates FDA Received09/19/2023
01/17/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/23/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-